Cargando…

The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma

BACKGROUND: There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Long, Xie, Feng, Yang, Cheng, Yu, Lihan, Zheng, Tao, Fu, Jun, Yang, Jiamei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358902/
https://www.ncbi.nlm.nih.gov/pubmed/25890009
http://dx.doi.org/10.1186/s12957-015-0464-2
_version_ 1782361305434292224
author Yan, Long
Xie, Feng
Yang, Cheng
Yu, Lihan
Zheng, Tao
Fu, Jun
Yang, Jiamei
author_facet Yan, Long
Xie, Feng
Yang, Cheng
Yu, Lihan
Zheng, Tao
Fu, Jun
Yang, Jiamei
author_sort Yan, Long
collection PubMed
description BACKGROUND: There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we did this retrospective study. METHODS: We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern Hepatobiliary Surgery Hospital in China. Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in the same period were also reviewed to make a comparison. In order to find out the definite survival information of SCC and ASC patients, 30 previous studies containing 37 primary hepatic SCC (16) and ASC (21) patients were reviewed, and their information of survival was analyzed together with the included patients in our hospital. RESULTS: Serum tumor markers showed significant differences between primary hepatic SCC/ASC and HCC patients, especially for serum alpha fetal protein (AFP) level and carbohydrate antigen 19-9 (CA 19-9). On the pathologic performance, primary SCC/ASC tumor was rarely accompanied with tumor capsule. They presented peripheral hepatic lymph node metastasis more likely and showed low proportion of microvascular invasion. The median survival time of primary hepatic SCC/ASC patients after liver resection (LR) was 15 months. And the 1-, 3-, 5-year survival rates after LR were 60%, 24%, and 12%, respectively. Significant difference was not discovered when SCC and ASC patients were compared with HCC patients (P = 0.294). The median survival time after LR for primary SCC and ASC patients was respectively 23 months and 13 months. CONCLUSIONS: The comprehensive application of some clinical characteristics, histopathologic features, and imaging findings may be useful for us in making definite diagnoses for primary hepatic SCC and ASC patients preoperatively. And the treatment of liver resection was effective for those patients who met the selection criteria for liver resection.
format Online
Article
Text
id pubmed-4358902
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43589022015-03-14 The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma Yan, Long Xie, Feng Yang, Cheng Yu, Lihan Zheng, Tao Fu, Jun Yang, Jiamei World J Surg Oncol Research BACKGROUND: There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we did this retrospective study. METHODS: We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern Hepatobiliary Surgery Hospital in China. Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in the same period were also reviewed to make a comparison. In order to find out the definite survival information of SCC and ASC patients, 30 previous studies containing 37 primary hepatic SCC (16) and ASC (21) patients were reviewed, and their information of survival was analyzed together with the included patients in our hospital. RESULTS: Serum tumor markers showed significant differences between primary hepatic SCC/ASC and HCC patients, especially for serum alpha fetal protein (AFP) level and carbohydrate antigen 19-9 (CA 19-9). On the pathologic performance, primary SCC/ASC tumor was rarely accompanied with tumor capsule. They presented peripheral hepatic lymph node metastasis more likely and showed low proportion of microvascular invasion. The median survival time of primary hepatic SCC/ASC patients after liver resection (LR) was 15 months. And the 1-, 3-, 5-year survival rates after LR were 60%, 24%, and 12%, respectively. Significant difference was not discovered when SCC and ASC patients were compared with HCC patients (P = 0.294). The median survival time after LR for primary SCC and ASC patients was respectively 23 months and 13 months. CONCLUSIONS: The comprehensive application of some clinical characteristics, histopathologic features, and imaging findings may be useful for us in making definite diagnoses for primary hepatic SCC and ASC patients preoperatively. And the treatment of liver resection was effective for those patients who met the selection criteria for liver resection. BioMed Central 2015-02-28 /pmc/articles/PMC4358902/ /pubmed/25890009 http://dx.doi.org/10.1186/s12957-015-0464-2 Text en © Yan et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yan, Long
Xie, Feng
Yang, Cheng
Yu, Lihan
Zheng, Tao
Fu, Jun
Yang, Jiamei
The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
title The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
title_full The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
title_fullStr The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
title_full_unstemmed The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
title_short The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
title_sort comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358902/
https://www.ncbi.nlm.nih.gov/pubmed/25890009
http://dx.doi.org/10.1186/s12957-015-0464-2
work_keys_str_mv AT yanlong thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT xiefeng thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yangcheng thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yulihan thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT zhengtao thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT fujun thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yangjiamei thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yanlong comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT xiefeng comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yangcheng comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yulihan comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT zhengtao comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT fujun comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma
AT yangjiamei comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma